Ultragenyx Pharmaceutical Inc. (RARE)
Track the next or latest earnings date for Ultragenyx Pharmaceutical Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
www.benzinga.com · 5 hours ago
Samsung guided to record second-quarter profit near 89 trillion won, out-earning Nvidia, yet the stock fell 7%. At 5 times earnings, is it a rare buy?
Q1 Earnings Highs And Lows: Verizon (NYSE:VZ) Vs The Rest Of The Consumer Discretionary - Wireless, Cable and Satellite Stocks - StockStorystockstory.org · 16 hours ago
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
What Rare Earths Stock Can Best Deliver Gains From America's Reshoring Boom?finance.yahoo.com · 3 days ago
All three of these rare-earth metal stocks are set to benefit from reshoring, so the real question is how much risk are you willing to take?
Here's Why Shares in USA Rare Earth Slumped 23% in Junefinance.yahoo.com · 2 days ago
A combination of three unrelated events sent the rare earth stock lower in June.
The Retirement Portfolio Sweet Spot Explained With Real Examplesfinance.yahoo.com · 7 hours ago
Oversold and undervalued sound like the same thing but they trap investors in very different ways. Three battered stocks currently sit in the rare overlap between both conditions, and only one of them truly belongs in a retirement portfolio.
Latest earnings date
Time not specified
Fiscal quarter: Dec/2025
EPS estimate: -$1.27
Revenue estimate: N/A
Market cap: $2.30B
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Feb 12, 2026 | Dec/2025 | Time not specified | -$1.27 | N/A |